Claus Kremoser PhD, MSc

Dr. Kremoser has studied biochemistry in Tübingen and Munich and has received his PhD based on work in the lab of Friedrich Bonhoeffer at the Max-Planck-Institute in Tübingen. In 1996, he became the first member of EY´s newly established life science practice in Germany to coordinate the first German EY biotech report which is now in its 18th year. After a position as VP Corporate Development at LION bioscience where he was instrumental in LION´s 100 M bioinformatics collaboration with Bayer AG and LION´s 220 M IPO in 2000, he became cofounder and CEO of Phenex in 2002, a position he has maintained since then.